StockSelector.com
  Research, Select, & Monitor Friday, September 25, 2020 7:58:31 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
GW Pharmaceuticals plc$100.44$1.941.97%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

GW Pharmaceuticals plc has an overall rank of 382 out of 7709 stocks based on 10 positive rankings and 8 negative rankings.

Positive Rankings
PEGValue
GW Pharmaceuticals plc has a PEG Value of $1,365.52. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 1,286.31% in the next year. Among companies with a PEG Value above the current stock price, GW Pharmaceuticals plc is ranked 108.
Target Prices
The average analysts' target price is $198.33 for GW Pharmaceuticals plc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, GW Pharmaceuticals plc is ranked 131.
Estimated Revenue Growth
GW Pharmaceuticals plc rank is 159
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 7.14%. Among companies that have had their estimates raised within the past month, GW Pharmaceuticals plc is ranked 159.
Historic Revenue Growth
GW Pharmaceuticals plc rank is 171
Low vPut/Call
GW Pharmaceuticals plc has a low Put/Call ratio of 0.09 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, GW Pharmaceuticals plc is ranked 177.
SSValue
The StockSelector Value for GW Pharmaceuticals plc is $381.14. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, GW Pharmaceuticals plc is ranked 321.
Debt-to-Equity
GW Pharmaceuticals plc rank is 433
Up EPS Surprise
GW Pharmaceuticals plc beat the consensus earnings estimate when it last reported quarterly earnings.
Low Put/Call
GW Pharmaceuticals plc has a low Put/Call ratio of 0.45 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, GW Pharmaceuticals plc is ranked 1447.
Negative Rankings
90 Day Loss
GW Pharmaceuticals plc rank is 778
Price-to-Sales
GW Pharmaceuticals plc rank is 845
Negative Net Margin
GW Pharmaceuticals plc rank is 1109
Price-to-Book
GW Pharmaceuticals plc rank is 1170
Negative ROE
GW Pharmaceuticals plc rank is 1722
Negative Cash Growth
GW Pharmaceuticals plc rank is 1861
Negative ROA
GW Pharmaceuticals plc rank is 1931
10 Day Loss
GW Pharmaceuticals plc rank is 3272







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.